Boston Globe Top Workplaces 2011
- Employees in region:
- HQ location:
- Watham, MA
ImmunoGen, Inc. develops targeted anticancer therapeutics using our expertise in cancer biology, engineered antibodies and highly potent cancer-cell killing agents. We have established expertise in the development and humanization of tumor-targeting antibodies. As is well accepted, engineered antibodies can do an excellent job of selectively binding to cancer cells, but are typically sub-optimal in their ability to actually kill cancer cells. Thus, we have developed specialized cancer-cell killing agents to serve as payloads – to be attached to such antibodies for targeted delivery to tumor cells.
Our payload agents are 1,000-10,000 times more potent than traditional chemotherapy agents. We also have developed engineered linkers that keep the payload firmly attached to the antibody while the whole therapy is circulating through the bloodstream and then release it once the therapy has reached and entered a cancer cell. We use our Targeted Antibody Payload (TAP) technology – together with our strong antibody expertise – to develop our own product candidates.
“I definitely feel appreciated here, I really admire the company for what it stands for and the products it is involved in. Our products are truly helping people. ”
“The senior managers at ImmunoGen are unique from other companies I have worked for because they are not hierarchical. This leaves their minds open to alternative views/opinions.”
“ImmunoGen is the leader in the field of immunoconjugates.”
“The training I have received in the laboratory. The formal training has enabled me to do my job as efficiently as possible and thereby the most productive to get the best possible result.”
“My work visibly contributes to the progress of projects.”